awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34251223-3F5D545C-3F25-4398-9CAC-B9F03FA79624
Q34251223-3F5D545C-3F25-4398-9CAC-B9F03FA79624
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34251223-3F5D545C-3F25-4398-9CAC-B9F03FA79624
Lopinavir/r no longer recommended as a first-line regimen: a comparative effectiveness analysis.
P2860
Q34251223-3F5D545C-3F25-4398-9CAC-B9F03FA79624
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34251223-3F5D545C-3F25-4398-9CAC-B9F03FA79624
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
74543dfa920d8948eeae3bd99cb5226e2e5af5db
P2860
Comparison of once-daily atazanavir with efavirenz, each in combination with fixed-dose zidovudine and lamivudine, as initial therapy for patients infected with HIV.